Unknown

Dataset Information

0

Decreased Prostaglandin D2 Levels in Major Depressive Disorder Are Associated with Depression-Like Behaviors.


ABSTRACT:

Background

Prostaglandin (PG) D2 is the most abundant prostaglandin in the mammalian brain. The physiological and pharmacological actions of PGD2 in the central nervous system seem to be associated with some of the symptoms exhibited by patients with major depressive disorder. Previous studies have found that PGD2 synthase was decreased in the cerebrospinal fluid of major depressive disorder patients. We speculated that there may be a dysregulation of PGD2 levels in major depressive disorder.

Methods

Ultra-performance liquid chromatography-tandem mass spectrometry coupled with a stable isotopic-labeled internal standard was used to determine PGD2 levels in the plasma of major depressive disorder patients and in the brains of depressive mice. A total of 32 drug-free major depressive disorder patients and 30 healthy controls were recruited. An animal model of depression was constructed by exposing mice to 5 weeks of chronic unpredictable mild stress. To explore the role of PGD2 in major depressive disorder, selenium tetrachloride was administered to simulate the change in PGD2 levels in mice.

Results

Mice exposed to chronic unpredictable mild stress exhibited depression-like behaviors, as indicated by reduced sucrose preference and increased immobility time in the forced swimming test. PGD2 levels in the plasma of major depressive disorder patients and in the brains of depressive mice were both decreased compared with their corresponding controls. Further inhibiting PGD2 production in mice resulted in an increased immobility time in the forced swimming test that could be reversed by imipramine.

Conclusion

Decreased PGD2 levels in major depressive disorder are associated with depression-like behaviors.

SUBMITTER: Chu C 

PROVIDER: S-EPMC5581486 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Decreased Prostaglandin D2 Levels in Major Depressive Disorder Are Associated with Depression-Like Behaviors.

Chu Cuilin C   Wei Hui H   Zhu Wanwan W   Shen Yan Y   Xu Qi Q  

The international journal of neuropsychopharmacology 20170901 9


<h4>Background</h4>Prostaglandin (PG) D2 is the most abundant prostaglandin in the mammalian brain. The physiological and pharmacological actions of PGD2 in the central nervous system seem to be associated with some of the symptoms exhibited by patients with major depressive disorder. Previous studies have found that PGD2 synthase was decreased in the cerebrospinal fluid of major depressive disorder patients. We speculated that there may be a dysregulation of PGD2 levels in major depressive diso  ...[more]

Similar Datasets

| S-EPMC7104369 | biostudies-literature
2011-10-04 | E-GEOD-19738 | biostudies-arrayexpress
| S-EPMC4939278 | biostudies-literature
2014-01-21 | E-GEOD-54222 | biostudies-arrayexpress
2014-01-25 | E-GEOD-54370 | biostudies-arrayexpress
| S-EPMC6246657 | biostudies-literature
2011-10-05 | GSE19738 | GEO
2012-04-27 | E-GEOD-37579 | biostudies-arrayexpress
| S-EPMC4047134 | biostudies-other
| S-EPMC5641476 | biostudies-literature